2-(4-CARBAMIMIDOYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE 2HCL, 97.0%, 5mg

3-Iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-ol, 98%, 100mg

(2-Methylquinolin-4-yl)(piperazin-1-yl)methanone, 95%, 1g

1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane, 99.0%, 1g

3-Phenyloxetan-3-ol, 95.0%, 250mg

3-BROMO-5-NITROQUINOLINE, 95.0%, 250mg

2-(tert-Butyl)-5-chloroisothiazol-3(2H)-one, 95.0%, 100mg

4-Hydroxy-7H-furo[3,2-g]chromen-7-one, 95.0%, 250mg

Fase de planificación PLPHi S100x/1,25 objetivo IOS de inmersión en aceite con corrección infinita. Distancia de trabajo 0,36 mm

N-Formyl-L-alanine>98.0%(T)1g

5-Ethynylthiophene-2-carbaldehyde, 98%, 100mg

2-(((BENZYLOXY)CARBONYL)AMINO)-5-HYDROXYBENZOIC ACID, 95.0%, 250mg

2',5'-dichloro-3-(3,4,5-trifluorophenyl)propiophenone, 97.0%, 1g